These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4299494)
1. [The genetic risk of oral contraceptive products]. de Grouchy J Sem Hop; 1967 Dec; 43(52):3336. PubMed ID: 4299494 [No Abstract] [Full Text] [Related]
2. Contraceptives and the conceptus. I. Chromosome abnormalities of the fetus and neonate related to maternal contraceptive history. Klinger HP; Glasser M; Kava HW Obstet Gynecol; 1976 Jul; 48(1):40-8. PubMed ID: 934573 [TBL] [Abstract][Full Text] [Related]
3. [Chromosomal and anatomic studies of pregnancies after discontinuation of steroid contraceptives]. Boué A; Boué J J Gynecol Obstet Biol Reprod (Paris); 1973 Mar; 2(2):141-54. PubMed ID: 4807234 [No Abstract] [Full Text] [Related]
5. Chromosomal abnormalities in the Kaiser-Permanente Birth Defects Study, with special reference to contraceptive use around the time of conception. Harlap S; Shiono PH; Ramcharan S; Golbus M; Bachman R; Mann J; Lewis JP Teratology; 1985 Jun; 31(3):381-7. PubMed ID: 4012647 [TBL] [Abstract][Full Text] [Related]
6. Possible genetic effects of some contraceptives. Matsunaga E Australas Nurses J; 1973 Jan; 2(19):9 passim. PubMed ID: 4486781 [No Abstract] [Full Text] [Related]
7. Chromosome abnormalities in oral contraceptive breakthrough pregnancies. Harlap S; Shiono P; Pellegrin F; Golbus M; Bachman R; Mann J; Schmidt L; Lewis JP Lancet; 1979 Jun; 1(8130):1342-3. PubMed ID: 87796 [No Abstract] [Full Text] [Related]
8. Chromosomes and oral contraceptives: aberrations in relation to neoplasia. Mills J; Bishun N; Williams D; Raven RW Clin Oncol; 1975 Jun; 1(2):141-7. PubMed ID: 1183102 [No Abstract] [Full Text] [Related]
9. [Genetic and teratogenic risks in substance-dependent patients]. Passarge E; Hauss-Albert H Verh Dtsch Ges Inn Med; 1990; 96():609-10. PubMed ID: 2092491 [No Abstract] [Full Text] [Related]
10. [Decreased contraceptive reliability in simultaneous administration of anticonvulsants and oral contraceptives?]. Lippert TH Med Monatsschr Pharm; 1991 Feb; 14(2):56-7. PubMed ID: 2027324 [No Abstract] [Full Text] [Related]
11. [Observation of tetraploid and heteroploid cells in blood cultures of 3 infants, children of mothers treated before and during pregnancy with anticonvulsant drugs]. De Toni E; Massimo L; Vianello MG; Dagna-Bricarelli F Minerva Pediatr; 1967 Nov; 19(47):2092-6. PubMed ID: 5606101 [No Abstract] [Full Text] [Related]
13. [Observation of tetraploid and heteroploid cells in leukocyte cultures of children subjected during their fetal life to the action of anticonvulsant drugs]. de Toni E; Massimo L; Vianello MG; Dagna Bricarelli F Ann Genet; 1966 Sep; 9(3):99-103. PubMed ID: 5298293 [No Abstract] [Full Text] [Related]
14. [Prenatal exposure to birth control pills: risk of fetal death and congenital malformations]. Jellesen R; Andersen AM Ugeskr Laeger; 2006 Jun; 168(25):2437-42. PubMed ID: 16824365 [TBL] [Abstract][Full Text] [Related]
15. LSD and chromosomes. Friedel W Chic Med Sch Q; 1970; 29(1):9-23. PubMed ID: 4912498 [No Abstract] [Full Text] [Related]
16. Fertility after discontinuation of oral contraceptives. Weisberg E Clin Reprod Fertil; 1982 Dec; 1(4):261-72. PubMed ID: 6764883 [TBL] [Abstract][Full Text] [Related]
17. [Chromosome changes and congenital malformations after use of estroprogestogens]. Pardini A; Pellico M; Giannardi I Riv Ital Ginecol; 1976; 57(3):195-203. PubMed ID: 801845 [No Abstract] [Full Text] [Related]
19. [Etiopathogenetic study of chromosome aberrations as a cause of reproductive failures]. Massobrio M; Coppo F; Rappelli F Minerva Ginecol; 1971 Jun; 23(11):507-35. PubMed ID: 5105805 [No Abstract] [Full Text] [Related]